

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | tachykinin receptor signaling pathway (GO:0007217) | 7.80203182 |
| 2 | pyrimidine nucleobase catabolic process (GO:0006208) | 7.10378306 |
| 3 | low-density lipoprotein particle clearance (GO:0034383) | 6.92880095 |
| 4 | regulation of somitogenesis (GO:0014807) | 6.41698339 |
| 5 | triglyceride catabolic process (GO:0019433) | 6.30399981 |
| 6 | regulation of sequestering of triglyceride (GO:0010889) | 5.98118951 |
| 7 | negative regulation of axon guidance (GO:1902668) | 5.71161134 |
| 8 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 5.55397336 |
| 9 | neutral lipid catabolic process (GO:0046461) | 5.52381022 |
| 10 | acylglycerol catabolic process (GO:0046464) | 5.52381022 |
| 11 | synaptic vesicle maturation (GO:0016188) | 5.45518196 |
| 12 | protein-chromophore linkage (GO:0018298) | 5.39481534 |
| 13 | nucleobase catabolic process (GO:0046113) | 5.25643258 |
| 14 | cell migration in hindbrain (GO:0021535) | 5.05331676 |
| 15 | midbrain development (GO:0030901) | 4.91728422 |
| 16 | melanin biosynthetic process (GO:0042438) | 4.81494609 |
| 17 | negative regulation of leukocyte chemotaxis (GO:0002689) | 4.79204612 |
| 18 | muscle cell fate commitment (GO:0042693) | 4.78968550 |
| 19 | acrosome reaction (GO:0007340) | 4.76582736 |
| 20 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 4.66451277 |
| 21 | axon extension involved in axon guidance (GO:0048846) | 4.66451277 |
| 22 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.61148285 |
| 23 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 4.56746570 |
| 24 | NADH metabolic process (GO:0006734) | 4.52108448 |
| 25 | melanin metabolic process (GO:0006582) | 4.46407577 |
| 26 | cellular response to epinephrine stimulus (GO:0071872) | 4.42298483 |
| 27 | retinal rod cell development (GO:0046548) | 4.24916321 |
| 28 | response to dietary excess (GO:0002021) | 4.21249082 |
| 29 | somite rostral/caudal axis specification (GO:0032525) | 4.16942887 |
| 30 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.16507843 |
| 31 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 4.16291445 |
| 32 | regulation of glycogen (starch) synthase activity (GO:2000465) | 4.15294495 |
| 33 | detection of temperature stimulus (GO:0016048) | 4.07625724 |
| 34 | barbed-end actin filament capping (GO:0051016) | 4.04700792 |
| 35 | secondary metabolite biosynthetic process (GO:0044550) | 4.03811537 |
| 36 | detection of light stimulus involved in sensory perception (GO:0050962) | 4.03226054 |
| 37 | detection of light stimulus involved in visual perception (GO:0050908) | 4.03226054 |
| 38 | transcytosis (GO:0045056) | 4.02088038 |
| 39 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 3.99948470 |
| 40 | regulation of cardioblast proliferation (GO:0003264) | 3.99948470 |
| 41 | response to epinephrine (GO:0071871) | 3.98488180 |
| 42 | regulation of axon guidance (GO:1902667) | 3.96588322 |
| 43 | lymph vessel development (GO:0001945) | 3.91103854 |
| 44 | receptor recycling (GO:0001881) | 3.90796994 |
| 45 | fatty acid homeostasis (GO:0055089) | 3.87359320 |
| 46 | maintenance of protein location in nucleus (GO:0051457) | 3.82454605 |
| 47 | regulation of telomere maintenance via telomerase (GO:0032210) | 3.81807313 |
| 48 | negative regulation of catenin import into nucleus (GO:0035414) | 3.81611530 |
| 49 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.80395561 |
| 50 | membrane hyperpolarization (GO:0060081) | 3.78270482 |
| 51 | positive regulation of glomerulus development (GO:0090193) | 3.77876881 |
| 52 | protein localization to synapse (GO:0035418) | 3.70001339 |
| 53 | glycerolipid catabolic process (GO:0046503) | 3.68992285 |
| 54 | outflow tract septum morphogenesis (GO:0003148) | 3.65465198 |
| 55 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.62565508 |
| 56 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.61255201 |
| 57 | regulation of uterine smooth muscle contraction (GO:0070472) | 3.60870825 |
| 58 | ovulation from ovarian follicle (GO:0001542) | 3.57055674 |
| 59 | negative regulation of granulocyte differentiation (GO:0030853) | 3.53529423 |
| 60 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.52924792 |
| 61 | negative regulation of dendrite development (GO:2000171) | 3.51019493 |
| 62 | polyol transport (GO:0015791) | 3.48597888 |
| 63 | outer ear morphogenesis (GO:0042473) | 3.48111214 |
| 64 | adult feeding behavior (GO:0008343) | 3.46397704 |
| 65 | regulation of synapse structural plasticity (GO:0051823) | 3.45876052 |
| 66 | sperm motility (GO:0030317) | 3.45362205 |
| 67 | synaptic vesicle endocytosis (GO:0048488) | 3.43329766 |
| 68 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.38740450 |
| 69 | positive regulation of protein kinase C signaling (GO:0090037) | 3.38368738 |
| 70 | protein heterotrimerization (GO:0070208) | 3.34905137 |
| 71 | lipid storage (GO:0019915) | 3.32539535 |
| 72 | sperm capacitation (GO:0048240) | 3.31688098 |
| 73 | positive regulation of lipid storage (GO:0010884) | 3.31684030 |
| 74 | retinal ganglion cell axon guidance (GO:0031290) | 3.29641547 |
| 75 | rhodopsin mediated signaling pathway (GO:0016056) | 3.26702616 |
| 76 | negative regulation of epidermis development (GO:0045683) | 3.26532483 |
| 77 | regulation of dopamine secretion (GO:0014059) | 3.25008895 |
| 78 | regulation of dopamine metabolic process (GO:0042053) | 3.24271462 |
| 79 | regulation of catecholamine metabolic process (GO:0042069) | 3.24271462 |
| 80 | response to auditory stimulus (GO:0010996) | 3.20865416 |
| 81 | negative regulation of axon extension (GO:0030517) | 3.19751967 |
| 82 | regulation of cholesterol storage (GO:0010885) | 3.19422333 |
| 83 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.19189255 |
| 84 | tooth mineralization (GO:0034505) | 3.18385958 |
| 85 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.17783899 |
| 86 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 3.17137858 |
| 87 | regulation of lipoprotein metabolic process (GO:0050746) | 3.15757959 |
| 88 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.15157119 |
| 89 | detection of light stimulus (GO:0009583) | 3.11502266 |
| 90 | DNA damage response, detection of DNA damage (GO:0042769) | 3.10302961 |
| 91 | cGMP-mediated signaling (GO:0019934) | 3.10040162 |
| 92 | nucleosome disassembly (GO:0006337) | 3.09901293 |
| 93 | protein-DNA complex disassembly (GO:0032986) | 3.09901293 |
| 94 | cardiac myofibril assembly (GO:0055003) | 3.09807670 |
| 95 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 3.09339660 |
| 96 | hyperosmotic salinity response (GO:0042538) | 3.08184266 |
| 97 | cranial nerve morphogenesis (GO:0021602) | 3.08053173 |
| 98 | negative regulation of microtubule polymerization (GO:0031115) | 3.07310894 |
| 99 | regulation of ruffle assembly (GO:1900027) | 3.07168507 |
| 100 | synaptic transmission, glutamatergic (GO:0035249) | 3.07112925 |
| 101 | positive regulation of myotube differentiation (GO:0010831) | 3.06873372 |
| 102 | negative chemotaxis (GO:0050919) | 3.06136775 |
| 103 | chromosome condensation (GO:0030261) | 3.05858937 |
| 104 | fatty acid beta-oxidation (GO:0006635) | 3.03915009 |
| 105 | heart contraction (GO:0060047) | 3.03628280 |
| 106 | heart process (GO:0003015) | 3.03628280 |
| 107 | triglyceride biosynthetic process (GO:0019432) | 3.03412052 |
| 108 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.03017128 |
| 109 | auditory behavior (GO:0031223) | 3.02780121 |
| 110 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.02183807 |
| 111 | negative regulation of metanephros development (GO:0072217) | 2.99562649 |
| 112 | white fat cell differentiation (GO:0050872) | 2.98693616 |
| 113 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.97544058 |
| 114 | left/right axis specification (GO:0070986) | 2.97251340 |
| 115 | embryonic viscerocranium morphogenesis (GO:0048703) | 2.96624213 |
| 116 | lipid particle organization (GO:0034389) | 2.96423355 |
| 117 | photoreceptor cell maintenance (GO:0045494) | 2.96284910 |
| 118 | chaperone-mediated protein transport (GO:0072321) | 2.95105261 |
| 119 | fatty acid catabolic process (GO:0009062) | 2.94982263 |
| 120 | diacylglycerol metabolic process (GO:0046339) | 2.94689877 |
| 121 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 2.94588114 |
| 122 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.94265638 |
| 123 | phototransduction (GO:0007602) | 2.93717512 |
| 124 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.92506104 |
| 125 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.92506104 |
| 126 | regulation of cardioblast differentiation (GO:0051890) | 2.91782957 |
| 127 | negative regulation of axonogenesis (GO:0050771) | 2.91396617 |
| 128 | fatty acid transmembrane transport (GO:1902001) | 2.88935734 |
| 129 | DNA packaging (GO:0006323) | 2.88795322 |
| 130 | coronary vasculature morphogenesis (GO:0060977) | 2.88723759 |
| 131 | ketone body metabolic process (GO:1902224) | 2.88554372 |
| 132 | brown fat cell differentiation (GO:0050873) | 2.88489245 |
| 133 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.86364245 |
| 134 | motor neuron axon guidance (GO:0008045) | 2.85842212 |
| 135 | vocalization behavior (GO:0071625) | 2.85217261 |
| 136 | amyloid precursor protein catabolic process (GO:0042987) | 2.85083077 |
| 137 | acylglycerol biosynthetic process (GO:0046463) | 2.84319554 |
| 138 | neutral lipid biosynthetic process (GO:0046460) | 2.84319554 |
| 139 | muscle organ morphogenesis (GO:0048644) | 2.84262307 |
| 140 | metanephric nephron epithelium development (GO:0072243) | 2.84201556 |
| 141 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.83289753 |
| 142 | ethanol oxidation (GO:0006069) | 2.83154257 |
| 143 | creatine metabolic process (GO:0006600) | 2.82548481 |
| 144 | rRNA transcription (GO:0009303) | 2.81733437 |
| 145 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.81582278 |
| 146 | negative regulation of cartilage development (GO:0061037) | 2.81547220 |
| 147 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 2.81250400 |
| 148 | striatum development (GO:0021756) | 2.80966945 |
| 149 | sexual reproduction (GO:0019953) | 2.80545755 |
| 150 | cellular ketone body metabolic process (GO:0046950) | 2.80446264 |
| 151 | regulation of gonadotropin secretion (GO:0032276) | 2.79321751 |
| 152 | photoreceptor cell development (GO:0042461) | 2.78337190 |
| 153 | ventricular system development (GO:0021591) | 2.77596968 |
| 154 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.77306658 |
| 155 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.77306658 |
| 156 | regulation of protein kinase A signaling (GO:0010738) | 2.76139136 |
| 157 | mating behavior (GO:0007617) | 2.76061427 |
| 158 | histone H4-K5 acetylation (GO:0043981) | 2.74995309 |
| 159 | histone H4-K8 acetylation (GO:0043982) | 2.74995309 |
| 160 | axon extension (GO:0048675) | 2.74214600 |
| 161 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.74180710 |
| 162 | regulation of respiratory system process (GO:0044065) | 2.74002286 |
| 163 | metanephric nephron tubule development (GO:0072234) | 2.73030742 |
| 164 | metanephric tubule development (GO:0072170) | 2.73030742 |
| 165 | regulation of cilium movement (GO:0003352) | 2.72908315 |
| 166 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.72026679 |
| 167 | negative regulation of amino acid transport (GO:0051956) | 2.71689765 |
| 168 | facial nerve structural organization (GO:0021612) | 2.71137560 |
| 169 | potassium ion export (GO:0071435) | 2.70753481 |
| 170 | layer formation in cerebral cortex (GO:0021819) | 2.70602602 |
| 171 | coenzyme catabolic process (GO:0009109) | 2.70426444 |
| 172 | lateral ventricle development (GO:0021670) | 2.70021075 |
| 173 | positive regulation of glycolytic process (GO:0045821) | 2.69739643 |
| 174 | photoreceptor cell differentiation (GO:0046530) | 2.68326648 |
| 175 | eye photoreceptor cell differentiation (GO:0001754) | 2.68326648 |
| 176 | spermatid nucleus differentiation (GO:0007289) | 2.67624621 |
| 177 | cardiovascular system development (GO:0072358) | 2.66549742 |
| 178 | eye photoreceptor cell development (GO:0042462) | 2.66340853 |
| 179 | plasma membrane fusion (GO:0045026) | 2.66155489 |
| 180 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.65996784 |
| 181 | detection of visible light (GO:0009584) | 2.65261150 |
| 182 | regulation of fatty acid oxidation (GO:0046320) | 2.64892054 |
| 183 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.64107367 |
| 184 | regulation of extent of cell growth (GO:0061387) | 2.63125859 |
| 185 | biotin metabolic process (GO:0006768) | 2.62807481 |
| 186 | G1 DNA damage checkpoint (GO:0044783) | 2.62784817 |
| 187 | cell migration involved in heart development (GO:0060973) | 2.62641491 |
| 188 | cardiac muscle contraction (GO:0060048) | 2.62026555 |
| 189 | mitochondrion distribution (GO:0048311) | 2.60872375 |
| 190 | neuron-neuron synaptic transmission (GO:0007270) | 2.60617553 |
| 191 | behavioral defense response (GO:0002209) | 2.59304024 |
| 192 | behavioral fear response (GO:0001662) | 2.59304024 |
| 193 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.58953640 |
| 194 | synaptic vesicle exocytosis (GO:0016079) | 2.58540797 |
| 195 | detection of external stimulus (GO:0009581) | 2.58528830 |
| 196 | glutamate secretion (GO:0014047) | 2.57925555 |
| 197 | doxorubicin metabolic process (GO:0044598) | 2.56980175 |
| 198 | daunorubicin metabolic process (GO:0044597) | 2.56980175 |
| 199 | response to pheromone (GO:0019236) | 11.7476177 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.63177081 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.38299522 |
| 3 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.96866984 |
| 4 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 3.83282741 |
| 5 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 3.83282741 |
| 6 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 3.83282741 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.52105182 |
| 8 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 3.11706837 |
| 9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.90893819 |
| 10 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.82221155 |
| 11 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.82221155 |
| 12 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.77805525 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.71071508 |
| 14 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.70797505 |
| 15 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.70644553 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.70641381 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.63386063 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.53835152 |
| 19 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.52652977 |
| 20 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.46416126 |
| 21 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.45767141 |
| 22 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.44155146 |
| 23 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.39247760 |
| 24 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.38819285 |
| 25 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.37848486 |
| 26 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.30376624 |
| 27 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.29727162 |
| 28 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.26905410 |
| 29 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.26589267 |
| 30 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 2.12770971 |
| 31 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.05275659 |
| 32 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.04287950 |
| 33 | P68_20966046_ChIP-Seq_HELA_Human | 2.03637069 |
| 34 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 2.03635325 |
| 35 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.02071827 |
| 36 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.01572031 |
| 37 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 2.01111794 |
| 38 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.99655300 |
| 39 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.97631953 |
| 40 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96443164 |
| 41 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.90403826 |
| 42 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.88901200 |
| 43 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.88669787 |
| 44 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.88566780 |
| 45 | * TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.85857845 |
| 46 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.85370887 |
| 47 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.85039464 |
| 48 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.79408210 |
| 49 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.78521920 |
| 50 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.74794742 |
| 51 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.74794742 |
| 52 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.73954431 |
| 53 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.73361919 |
| 54 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.72930506 |
| 55 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.69356507 |
| 56 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.69291261 |
| 57 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.66928739 |
| 58 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.66906743 |
| 59 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.66097212 |
| 60 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.65947072 |
| 61 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.65102072 |
| 62 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.61733555 |
| 63 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.61038923 |
| 64 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.58685504 |
| 65 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.58364222 |
| 66 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.57467828 |
| 67 | SA1_27219007_Chip-Seq_Bcells_Human | 1.57196171 |
| 68 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.56881341 |
| 69 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.56678293 |
| 70 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.56285800 |
| 71 | * ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.50978742 |
| 72 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.50623301 |
| 73 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.48170550 |
| 74 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.47610119 |
| 75 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.47457926 |
| 76 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.46360283 |
| 77 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.45699509 |
| 78 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.45361872 |
| 79 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.44687817 |
| 80 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.44364078 |
| 81 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.43258160 |
| 82 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.41385602 |
| 83 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.40428016 |
| 84 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.38599172 |
| 85 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.37540413 |
| 86 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.37339132 |
| 87 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.36963228 |
| 88 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.36961621 |
| 89 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.36508698 |
| 90 | ERA_21632823_ChIP-Seq_H3396_Human | 1.36505590 |
| 91 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.35958314 |
| 92 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.34522538 |
| 93 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.33002687 |
| 94 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.31922198 |
| 95 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.31879154 |
| 96 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.26741100 |
| 97 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 1.26335828 |
| 98 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.25904208 |
| 99 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.25411056 |
| 100 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.24341357 |
| 101 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.24341327 |
| 102 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.24289140 |
| 103 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.22023677 |
| 104 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.21646028 |
| 105 | KDM2B_26808549_Chip-Seq_K562_Human | 1.20815424 |
| 106 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.19137498 |
| 107 | SOX3_22085726_ChIP-Seq_NPCs_Mouse | 1.18463368 |
| 108 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.14842379 |
| 109 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.14540619 |
| 110 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.14152678 |
| 111 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.13747371 |
| 112 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.13623338 |
| 113 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.12875412 |
| 114 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.12396513 |
| 115 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.12248138 |
| 116 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.11559930 |
| 117 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.11025257 |
| 118 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.10807641 |
| 119 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.10692171 |
| 120 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.07413893 |
| 121 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.07009644 |
| 122 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.06733242 |
| 123 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.05734098 |
| 124 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.05203043 |
| 125 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.04169327 |
| 126 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.04085668 |
| 127 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.02789200 |
| 128 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.02123852 |
| 129 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.01928097 |
| 130 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.00258203 |
| 131 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.99703246 |
| 132 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.99513169 |
| 133 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.99476108 |
| 134 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98370623 |
| 135 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.98305210 |
| 136 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.98194571 |
| 137 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.96890242 |
| 138 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.96240252 |
| 139 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.96112538 |
| 140 | * AR_19668381_ChIP-Seq_PC3_Human | 0.95325800 |
| 141 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.94426824 |
| 142 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.93304228 |
| 143 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.91156221 |
| 144 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.90784449 |
| 145 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.89614279 |
| 146 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.88561664 |
| 147 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.88230980 |
| 148 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.87119438 |
| 149 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85009760 |
| 150 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.84961377 |
| 151 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.84551789 |
| 152 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.84374469 |
| 153 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.84282379 |
| 154 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.83999691 |
| 155 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.82388655 |
| 156 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82341375 |
| 157 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.81831488 |
| 158 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.81600223 |
| 159 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.80499926 |
| 160 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.80037475 |
| 161 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.77985103 |
| 162 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.77642147 |
| 163 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.77525552 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 7.68097834 |
| 2 | MP0003011_delayed_dark_adaptation | 4.98846984 |
| 3 | MP0005666_abnormal_adipose_tissue | 4.43571282 |
| 4 | MP0010030_abnormal_orbit_morphology | 4.19599724 |
| 5 | MP0005375_adipose_tissue_phenotype | 3.51997728 |
| 6 | MP0004130_abnormal_muscle_cell | 3.37172729 |
| 7 | MP0005551_abnormal_eye_electrophysiolog | 3.32734607 |
| 8 | MP0001486_abnormal_startle_reflex | 3.25682045 |
| 9 | MP0006292_abnormal_olfactory_placode | 3.12487916 |
| 10 | MP0003122_maternal_imprinting | 2.83530556 |
| 11 | MP0004270_analgesia | 2.73659827 |
| 12 | MP0000751_myopathy | 2.73199247 |
| 13 | MP0005171_absent_coat_pigmentation | 2.72995836 |
| 14 | MP0000003_abnormal_adipose_tissue | 2.63618012 |
| 15 | MP0002971_abnormal_brown_adipose | 2.62127055 |
| 16 | MP0005253_abnormal_eye_physiology | 2.58158491 |
| 17 | MP0006138_congestive_heart_failure | 2.57084613 |
| 18 | MP0004858_abnormal_nervous_system | 2.56246257 |
| 19 | MP0004084_abnormal_cardiac_muscle | 2.53318571 |
| 20 | MP0006072_abnormal_retinal_apoptosis | 2.52855957 |
| 21 | MP0006276_abnormal_autonomic_nervous | 2.51209347 |
| 22 | MP0003136_yellow_coat_color | 2.48253358 |
| 23 | MP0003890_abnormal_embryonic-extraembry | 2.47493042 |
| 24 | MP0004859_abnormal_synaptic_plasticity | 2.36810792 |
| 25 | MP0002735_abnormal_chemical_nociception | 2.36762369 |
| 26 | MP0005410_abnormal_fertilization | 2.36357488 |
| 27 | MP0005394_taste/olfaction_phenotype | 2.34757527 |
| 28 | MP0005499_abnormal_olfactory_system | 2.34757527 |
| 29 | MP0003880_abnormal_central_pattern | 2.32752262 |
| 30 | MP0009115_abnormal_fat_cell | 2.32040705 |
| 31 | MP0005275_abnormal_skin_tensile | 2.29884908 |
| 32 | MP0003959_abnormal_lean_body | 2.29595453 |
| 33 | MP0004185_abnormal_adipocyte_glucose | 2.26314787 |
| 34 | MP0000566_synostosis | 2.18203304 |
| 35 | MP0004215_abnormal_myocardial_fiber | 2.18189523 |
| 36 | MP0000372_irregular_coat_pigmentation | 2.14502116 |
| 37 | MP0003705_abnormal_hypodermis_morpholog | 2.09951910 |
| 38 | MP0004036_abnormal_muscle_relaxation | 2.07081793 |
| 39 | MP0003315_abnormal_perineum_morphology | 2.06415114 |
| 40 | MP0003635_abnormal_synaptic_transmissio | 2.04375440 |
| 41 | MP0005423_abnormal_somatic_nervous | 2.03396103 |
| 42 | MP0002184_abnormal_innervation | 2.01553704 |
| 43 | MP0002734_abnormal_mechanical_nocicepti | 1.99743946 |
| 44 | MP0001968_abnormal_touch/_nociception | 1.96267749 |
| 45 | MP0002752_abnormal_somatic_nervous | 1.93241082 |
| 46 | MP0003879_abnormal_hair_cell | 1.89831596 |
| 47 | MP0002733_abnormal_thermal_nociception | 1.87600047 |
| 48 | MP0000778_abnormal_nervous_system | 1.82358717 |
| 49 | MP0003828_pulmonary_edema | 1.78941273 |
| 50 | MP0002837_dystrophic_cardiac_calcinosis | 1.78235357 |
| 51 | MP0005391_vision/eye_phenotype | 1.73526528 |
| 52 | MP0003878_abnormal_ear_physiology | 1.72486840 |
| 53 | MP0005377_hearing/vestibular/ear_phenot | 1.72486840 |
| 54 | MP0002063_abnormal_learning/memory/cond | 1.71919497 |
| 55 | MP0000733_abnormal_muscle_development | 1.71905725 |
| 56 | MP0002653_abnormal_ependyma_morphology | 1.69671181 |
| 57 | MP0002876_abnormal_thyroid_physiology | 1.68493031 |
| 58 | MP0002638_abnormal_pupillary_reflex | 1.64891240 |
| 59 | MP0001879_abnormal_lymphatic_vessel | 1.64094531 |
| 60 | MP0002332_abnormal_exercise_endurance | 1.63823388 |
| 61 | MP0000534_abnormal_ureter_morphology | 1.61947674 |
| 62 | MP0005195_abnormal_posterior_eye | 1.61230680 |
| 63 | MP0005408_hypopigmentation | 1.59935006 |
| 64 | MP0002970_abnormal_white_adipose | 1.59708247 |
| 65 | MP0004742_abnormal_vestibular_system | 1.58553148 |
| 66 | MP0002272_abnormal_nervous_system | 1.57368358 |
| 67 | MP0005330_cardiomyopathy | 1.56990276 |
| 68 | MP0005623_abnormal_meninges_morphology | 1.56453923 |
| 69 | MP0003121_genomic_imprinting | 1.56372250 |
| 70 | MP0002234_abnormal_pharynx_morphology | 1.55735792 |
| 71 | MP0001970_abnormal_pain_threshold | 1.55514915 |
| 72 | MP0003646_muscle_fatigue | 1.54453047 |
| 73 | MP0002882_abnormal_neuron_morphology | 1.53335630 |
| 74 | MP0008961_abnormal_basal_metabolism | 1.51640781 |
| 75 | MP0000749_muscle_degeneration | 1.49375189 |
| 76 | MP0002751_abnormal_autonomic_nervous | 1.48185844 |
| 77 | MP0004381_abnormal_hair_follicle | 1.48137870 |
| 78 | MP0002572_abnormal_emotion/affect_behav | 1.43743478 |
| 79 | MP0002089_abnormal_postnatal_growth/wei | 1.42776585 |
| 80 | MP0010329_abnormal_lipoprotein_level | 1.41577607 |
| 81 | MP0008438_abnormal_cutaneous_collagen | 1.41019444 |
| 82 | MP0005334_abnormal_fat_pad | 1.40255861 |
| 83 | MP0005385_cardiovascular_system_phenoty | 1.38531379 |
| 84 | MP0001544_abnormal_cardiovascular_syste | 1.38531379 |
| 85 | MP0002736_abnormal_nociception_after | 1.38360794 |
| 86 | MP0004087_abnormal_muscle_fiber | 1.38281744 |
| 87 | MP0000026_abnormal_inner_ear | 1.35100507 |
| 88 | MP0002229_neurodegeneration | 1.34872718 |
| 89 | MP0005197_abnormal_uvea_morphology | 1.30592954 |
| 90 | MP0001963_abnormal_hearing_physiology | 1.29174744 |
| 91 | MP0002557_abnormal_social/conspecific_i | 1.29085383 |
| 92 | MP0001440_abnormal_grooming_behavior | 1.27350360 |
| 93 | MP0005535_abnormal_body_temperature | 1.27267800 |
| 94 | MP0002697_abnormal_eye_size | 1.26371281 |
| 95 | MP0002796_impaired_skin_barrier | 1.24225305 |
| 96 | MP0000759_abnormal_skeletal_muscle | 1.23474039 |
| 97 | MP0008789_abnormal_olfactory_epithelium | 1.22977066 |
| 98 | MP0003137_abnormal_impulse_conducting | 1.22626116 |
| 99 | MP0001661_extended_life_span | 1.20297914 |
| 100 | MP0002064_seizures | 1.19944569 |
| 101 | MP0001984_abnormal_olfaction | 1.19413388 |
| 102 | MP0003385_abnormal_body_wall | 1.17398462 |
| 103 | MP0003938_abnormal_ear_development | 1.17017709 |
| 104 | MP0004510_myositis | 1.16999160 |
| 105 | MP0000015_abnormal_ear_pigmentation | 1.16545197 |
| 106 | MP0002972_abnormal_cardiac_muscle | 1.15711101 |
| 107 | MP0000049_abnormal_middle_ear | 1.15648120 |
| 108 | MP0003186_abnormal_redox_activity | 1.15527009 |
| 109 | MP0004264_abnormal_extraembryonic_tissu | 1.14076485 |
| 110 | MP0000013_abnormal_adipose_tissue | 1.12178966 |
| 111 | MP0006036_abnormal_mitochondrial_physio | 1.11990499 |
| 112 | MP0002932_abnormal_joint_morphology | 1.11834433 |
| 113 | MP0000955_abnormal_spinal_cord | 1.11291625 |
| 114 | MP0000678_abnormal_parathyroid_gland | 1.10283690 |
| 115 | MP0005379_endocrine/exocrine_gland_phen | 1.08842453 |
| 116 | MP0003942_abnormal_urinary_system | 1.07782530 |
| 117 | MP0000343_altered_response_to | 1.07593823 |
| 118 | MP0005620_abnormal_muscle_contractility | 1.07440774 |
| 119 | MP0002067_abnormal_sensory_capabilities | 1.07386805 |
| 120 | MP0002254_reproductive_system_inflammat | 1.07331830 |
| 121 | MP0009250_abnormal_appendicular_skeleto | 1.06841745 |
| 122 | MP0000631_abnormal_neuroendocrine_gland | 1.05984275 |
| 123 | MP0000371_diluted_coat_color | 1.05094615 |
| 124 | MP0002092_abnormal_eye_morphology | 1.04684611 |
| 125 | MP0005503_abnormal_tendon_morphology | 1.04229543 |
| 126 | MP0003861_abnormal_nervous_system | 1.02006845 |
| 127 | MP0010630_abnormal_cardiac_muscle | 1.00282071 |
| 128 | MP0001324_abnormal_eye_pigmentation | 0.99934339 |
| 129 | MP0005448_abnormal_energy_balance | 0.99742600 |
| 130 | MP0003279_aneurysm | 0.98505597 |
| 131 | MP0008775_abnormal_heart_ventricle | 0.98200124 |
| 132 | MP0003950_abnormal_plasma_membrane | 0.95983277 |
| 133 | MP0002877_abnormal_melanocyte_morpholog | 0.95184677 |
| 134 | MP0002090_abnormal_vision | 0.95013293 |
| 135 | MP0002249_abnormal_larynx_morphology | 0.94354750 |
| 136 | MP0001502_abnormal_circadian_rhythm | 0.94153228 |
| 137 | MP0002233_abnormal_nose_morphology | 0.93958162 |
| 138 | MP0002118_abnormal_lipid_homeostasis | 0.91769639 |
| 139 | MP0005167_abnormal_blood-brain_barrier | 0.91448090 |
| 140 | MP0009745_abnormal_behavioral_response | 0.91092163 |
| 141 | MP0002909_abnormal_adrenal_gland | 0.90840631 |
| 142 | MP0001346_abnormal_lacrimal_gland | 0.90635702 |
| 143 | MP0004133_heterotaxia | 0.90382164 |
| 144 | MP0002822_catalepsy | 0.88539410 |
| 145 | MP0010368_abnormal_lymphatic_system | 0.87006159 |
| 146 | MP0005452_abnormal_adipose_tissue | 0.86956502 |
| 147 | MP0001286_abnormal_eye_development | 0.86535683 |
| 148 | MP0002269_muscular_atrophy | 0.85122529 |
| 149 | MP0001293_anophthalmia | 0.82914650 |
| 150 | MP0002102_abnormal_ear_morphology | 0.82152680 |
| 151 | MP0001485_abnormal_pinna_reflex | 0.82115660 |
| 152 | MP0004885_abnormal_endolymph | 0.81710001 |
| 153 | MP0002114_abnormal_axial_skeleton | 0.81613856 |
| 154 | MP0009046_muscle_twitch | 0.81408894 |
| 155 | MP0001727_abnormal_embryo_implantation | 0.80486308 |
| 156 | MP0004811_abnormal_neuron_physiology | 0.79222917 |
| 157 | MP0002081_perinatal_lethality | 0.78497740 |
| 158 | MP0005257_abnormal_intraocular_pressure | 0.77733213 |
| 159 | MP0003698_abnormal_male_reproductive | 0.76792067 |
| 160 | MP0002152_abnormal_brain_morphology | 0.76328188 |
| 161 | MP0001849_ear_inflammation | 0.76249224 |
| 162 | MP0002127_abnormal_cardiovascular_syste | 0.75732886 |
| 163 | MP0003787_abnormal_imprinting | 0.75621580 |
| 164 | MP0004484_altered_response_of | 0.74861205 |
| 165 | MP0000249_abnormal_blood_vessel | 0.74859977 |
| 166 | MP0000750_abnormal_muscle_regeneration | 0.74311547 |
| 167 | MP0002277_abnormal_respiratory_mucosa | 0.74190928 |
| 168 | MP0004142_abnormal_muscle_tone | 0.74094167 |
| 169 | MP0000762_abnormal_tongue_morphology | 0.73022363 |
| 170 | MP0005647_abnormal_sex_gland | 0.71651969 |
| 171 | MP0005369_muscle_phenotype | 0.71471030 |
| 172 | MP0004272_abnormal_basement_membrane | 0.70797208 |
| 173 | MP0002095_abnormal_skin_pigmentation | 0.70313496 |
| 174 | MP0002060_abnormal_skin_morphology | 0.70194690 |
| 175 | MP0000579_abnormal_nail_morphology | 0.69867763 |
| 176 | MP0002066_abnormal_motor_capabilities/c | 0.69574722 |
| 177 | MP0002108_abnormal_muscle_morphology | 0.69509583 |
| 178 | MP0009053_abnormal_anal_canal | 0.67318421 |
| 179 | MP0004782_abnormal_surfactant_physiolog | 0.66534004 |
| 180 | MP0009780_abnormal_chondrocyte_physiolo | 0.66306675 |
| 181 | MP0005266_abnormal_metabolism | 0.62579018 |
| 182 | MP0005595_abnormal_vascular_smooth | 0.62422797 |
| 183 | MP0005075_abnormal_melanosome_morpholog | 0.61059408 |
| 184 | MP0002295_abnormal_pulmonary_circulatio | 0.58684598 |
| 185 | MP0000747_muscle_weakness | 0.58473448 |
| 186 | MP0000681_abnormal_thyroid_gland | 0.58048266 |
| 187 | MP0003948_abnormal_gas_homeostasis | 0.57677570 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 6.30840975 |
| 2 | Bilateral microphthalmos (HP:0007633) | 4.98845369 |
| 3 | Pendular nystagmus (HP:0012043) | 4.97715805 |
| 4 | Acanthosis nigricans (HP:0000956) | 4.88008927 |
| 5 | Congenital malformation of the right heart (HP:0011723) | 4.72387920 |
| 6 | Double outlet right ventricle (HP:0001719) | 4.72387920 |
| 7 | Asymmetric septal hypertrophy (HP:0001670) | 4.45538859 |
| 8 | Ventricular tachycardia (HP:0004756) | 4.41417290 |
| 9 | Hypertriglyceridemia (HP:0002155) | 4.39803654 |
| 10 | Neoplasm of the heart (HP:0100544) | 4.33166510 |
| 11 | Oligomenorrhea (HP:0000876) | 4.27994909 |
| 12 | Concave nail (HP:0001598) | 4.09346711 |
| 13 | Decreased central vision (HP:0007663) | 3.96820000 |
| 14 | Increased variability in muscle fiber diameter (HP:0003557) | 3.88672828 |
| 15 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.83177156 |
| 16 | Increased corneal curvature (HP:0100692) | 3.76313606 |
| 17 | Keratoconus (HP:0000563) | 3.76313606 |
| 18 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.58837927 |
| 19 | Muscle fiber splitting (HP:0003555) | 3.58185219 |
| 20 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.56674296 |
| 21 | Hepatoblastoma (HP:0002884) | 3.55167598 |
| 22 | Febrile seizures (HP:0002373) | 3.51366351 |
| 23 | Ependymoma (HP:0002888) | 3.45501424 |
| 24 | Lipoatrophy (HP:0100578) | 3.45055324 |
| 25 | Sudden death (HP:0001699) | 3.44805268 |
| 26 | Failure to thrive in infancy (HP:0001531) | 3.38646796 |
| 27 | Septo-optic dysplasia (HP:0100842) | 3.25707563 |
| 28 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.25155388 |
| 29 | Atrial fibrillation (HP:0005110) | 3.15768212 |
| 30 | Generalized hypotonia (HP:0001290) | 3.15741522 |
| 31 | Supraventricular tachycardia (HP:0004755) | 3.15705972 |
| 32 | Supraventricular arrhythmia (HP:0005115) | 3.12203332 |
| 33 | Preauricular pit (HP:0004467) | 3.12196324 |
| 34 | Periauricular skin pits (HP:0100277) | 3.12196324 |
| 35 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.11359728 |
| 36 | Hypoplasia of the fovea (HP:0007750) | 3.11359728 |
| 37 | Focal seizures (HP:0007359) | 3.08861592 |
| 38 | Abnormality of the aortic arch (HP:0012303) | 3.08278839 |
| 39 | Protrusio acetabuli (HP:0003179) | 3.06353229 |
| 40 | Focal motor seizures (HP:0011153) | 3.02702648 |
| 41 | Primary atrial arrhythmia (HP:0001692) | 2.99473471 |
| 42 | White forelock (HP:0002211) | 2.96364251 |
| 43 | Hypoplastic left heart (HP:0004383) | 2.92975482 |
| 44 | Scotoma (HP:0000575) | 2.91630589 |
| 45 | Insulin resistance (HP:0000855) | 2.86431805 |
| 46 | Bulbar palsy (HP:0001283) | 2.85816444 |
| 47 | Abnormality of the lower motor neuron (HP:0002366) | 2.85705859 |
| 48 | Chorioretinal atrophy (HP:0000533) | 2.84522284 |
| 49 | Pulmonary artery stenosis (HP:0004415) | 2.83134259 |
| 50 | Visual hallucinations (HP:0002367) | 2.78992583 |
| 51 | Hyporeflexia of lower limbs (HP:0002600) | 2.75119091 |
| 52 | Cone-rod dystrophy (HP:0000548) | 2.74880166 |
| 53 | Tented upper lip vermilion (HP:0010804) | 2.69138172 |
| 54 | Increased connective tissue (HP:0009025) | 2.69099985 |
| 55 | Hemiparesis (HP:0001269) | 2.67386644 |
| 56 | Spinal rigidity (HP:0003306) | 2.65520939 |
| 57 | Bifid tongue (HP:0010297) | 2.63744131 |
| 58 | Transposition of the great arteries (HP:0001669) | 2.63634395 |
| 59 | Abnormal connection of the cardiac segments (HP:0011545) | 2.63634395 |
| 60 | Abnormal ventriculo-arterial connection (HP:0011563) | 2.63634395 |
| 61 | Cerebral aneurysm (HP:0004944) | 2.63404674 |
| 62 | Astrocytoma (HP:0009592) | 2.62401130 |
| 63 | Abnormality of the astrocytes (HP:0100707) | 2.62401130 |
| 64 | Dilated cardiomyopathy (HP:0001644) | 2.61817594 |
| 65 | Subaortic stenosis (HP:0001682) | 2.60784803 |
| 66 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.60784803 |
| 67 | Central scotoma (HP:0000603) | 2.60385321 |
| 68 | Difficulty running (HP:0009046) | 2.60071126 |
| 69 | Colitis (HP:0002583) | 2.58790365 |
| 70 | Right ventricular cardiomyopathy (HP:0011663) | 2.58191982 |
| 71 | Severe Myopia (HP:0011003) | 2.56579639 |
| 72 | Nausea (HP:0002018) | 2.56263613 |
| 73 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.56050757 |
| 74 | Atrioventricular block (HP:0001678) | 2.55627329 |
| 75 | Generalized aminoaciduria (HP:0002909) | 2.55590653 |
| 76 | Increased serum pyruvate (HP:0003542) | 2.53195941 |
| 77 | Abnormality of glycolysis (HP:0004366) | 2.53195941 |
| 78 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.50970213 |
| 79 | Bell-shaped thorax (HP:0001591) | 2.48500710 |
| 80 | Dyschromatopsia (HP:0007641) | 2.47807929 |
| 81 | Hypochromic microcytic anemia (HP:0004840) | 2.47599858 |
| 82 | Patchy hypopigmentation of hair (HP:0011365) | 2.46891961 |
| 83 | Unilateral renal agenesis (HP:0000122) | 2.45581004 |
| 84 | Neoplasm of striated muscle (HP:0009728) | 2.44432375 |
| 85 | Upper limb muscle weakness (HP:0003484) | 2.43389817 |
| 86 | Frequent falls (HP:0002359) | 2.39894114 |
| 87 | Sex reversal (HP:0012245) | 2.37723108 |
| 88 | Abnormal sex determination (HP:0012244) | 2.37723108 |
| 89 | Hypoplasia of the iris (HP:0007676) | 2.35168945 |
| 90 | Hypotrichosis (HP:0001006) | 2.33808597 |
| 91 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.32768519 |
| 92 | Hypoplastic heart (HP:0001961) | 2.32416669 |
| 93 | Polar cataract (HP:0010696) | 2.32040465 |
| 94 | Abnormality of the fovea (HP:0000493) | 2.31611887 |
| 95 | Long toe (HP:0010511) | 2.31451401 |
| 96 | Type 1 muscle fiber predominance (HP:0003803) | 2.29844840 |
| 97 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.29689313 |
| 98 | Amblyopia (HP:0000646) | 2.29122227 |
| 99 | Amyotrophic lateral sclerosis (HP:0007354) | 2.28047459 |
| 100 | Dialeptic seizures (HP:0011146) | 2.26809975 |
| 101 | Polyphagia (HP:0002591) | 2.25634434 |
| 102 | Bladder neoplasm (HP:0009725) | 2.24455055 |
| 103 | Bladder carcinoma (HP:0002862) | 2.24455055 |
| 104 | Exotropia (HP:0000577) | 2.24198729 |
| 105 | Skin pits (HP:0100276) | 2.20543756 |
| 106 | Growth hormone deficiency (HP:0000824) | 2.20051477 |
| 107 | Bundle branch block (HP:0011710) | 2.19423371 |
| 108 | Vertebral compression fractures (HP:0002953) | 2.19282127 |
| 109 | Cortical dysplasia (HP:0002539) | 2.18671828 |
| 110 | Absence seizures (HP:0002121) | 2.18536578 |
| 111 | Resting tremor (HP:0002322) | 2.17781421 |
| 112 | Rhabdomyolysis (HP:0003201) | 2.17423601 |
| 113 | Rib fusion (HP:0000902) | 2.17212228 |
| 114 | Tongue fasciculations (HP:0001308) | 2.16657823 |
| 115 | Leiomyosarcoma (HP:0100243) | 2.15967773 |
| 116 | Uterine leiomyosarcoma (HP:0002891) | 2.15967773 |
| 117 | Abnormal atrioventricular conduction (HP:0005150) | 2.15370481 |
| 118 | Epileptic encephalopathy (HP:0200134) | 2.15286243 |
| 119 | Abnormality of the costochondral junction (HP:0000919) | 2.14956152 |
| 120 | Abnormality of macular pigmentation (HP:0008002) | 2.14196871 |
| 121 | Hypercholesterolemia (HP:0003124) | 2.13898723 |
| 122 | Short humerus (HP:0005792) | 2.10808567 |
| 123 | Neck muscle weakness (HP:0000467) | 2.09586564 |
| 124 | Renal cell carcinoma (HP:0005584) | 2.09179248 |
| 125 | Skin nodule (HP:0200036) | 2.08956576 |
| 126 | Exercise-induced myalgia (HP:0003738) | 2.08680624 |
| 127 | Hypoplastic ischia (HP:0003175) | 2.08253604 |
| 128 | Anterior segment dysgenesis (HP:0007700) | 2.07940404 |
| 129 | Foot dorsiflexor weakness (HP:0009027) | 2.07099056 |
| 130 | Hypoventilation (HP:0002791) | 2.06378915 |
| 131 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.06133466 |
| 132 | Lymphangioma (HP:0100764) | 2.05539094 |
| 133 | Increased IgM level (HP:0003496) | 2.05417953 |
| 134 | Abnormality of the lacrimal duct (HP:0011481) | 2.05126072 |
| 135 | Syncope (HP:0001279) | 2.05013245 |
| 136 | Atelectasis (HP:0100750) | 2.04734782 |
| 137 | Myoglobinuria (HP:0002913) | 2.04712630 |
| 138 | Heart block (HP:0012722) | 2.04644169 |
| 139 | Back pain (HP:0003418) | 2.04416005 |
| 140 | Abolished electroretinogram (ERG) (HP:0000550) | 2.04364143 |
| 141 | Aplasia/Hypoplasia of the lens (HP:0008063) | 2.03020224 |
| 142 | Stridor (HP:0010307) | 2.02916084 |
| 143 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.02876196 |
| 144 | Anal stenosis (HP:0002025) | 2.02518998 |
| 145 | Myocardial infarction (HP:0001658) | 2.02507977 |
| 146 | Ectopia lentis (HP:0001083) | 2.01501832 |
| 147 | Truncus arteriosus (HP:0001660) | 2.00580285 |
| 148 | Severe visual impairment (HP:0001141) | 2.00153745 |
| 149 | Bone cyst (HP:0012062) | 2.00097159 |
| 150 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.99964446 |
| 151 | Abnormality of the ischium (HP:0003174) | 1.99944652 |
| 152 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.98014481 |
| 153 | Hypopigmentation of the fundus (HP:0007894) | 1.97960565 |
| 154 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.97467356 |
| 155 | Macular degeneration (HP:0000608) | 1.97227039 |
| 156 | Axonal loss (HP:0003447) | 1.96921382 |
| 157 | Metaphyseal dysplasia (HP:0100255) | 1.95715501 |
| 158 | Abnormality of the nasal mucosa (HP:0000433) | 1.95715240 |
| 159 | Hyperlipoproteinemia (HP:0010980) | 1.95005851 |
| 160 | Distal lower limb muscle weakness (HP:0009053) | 1.94640986 |
| 161 | Hypoalphalipoproteinemia (HP:0003233) | 1.94173749 |
| 162 | Infantile muscular hypotonia (HP:0008947) | 1.93841578 |
| 163 | Abnormality of the labia minora (HP:0012880) | 1.93295702 |
| 164 | Abnormality of the foot musculature (HP:0001436) | 1.92764025 |
| 165 | Horizontal nystagmus (HP:0000666) | 1.91433643 |
| 166 | Muscle fibrillation (HP:0010546) | 1.91375449 |
| 167 | Nasolacrimal duct obstruction (HP:0000579) | 1.90800890 |
| 168 | Absent speech (HP:0001344) | 1.90635943 |
| 169 | Ocular albinism (HP:0001107) | 1.90359423 |
| 170 | Albinism (HP:0001022) | 1.89983207 |
| 171 | Increased muscle lipid content (HP:0009058) | 1.89622067 |
| 172 | Type II diabetes mellitus (HP:0005978) | 1.89125633 |
| 173 | Broad nasal tip (HP:0000455) | 1.88839132 |
| 174 | Open mouth (HP:0000194) | 1.87673153 |
| 175 | Short 5th finger (HP:0009237) | 1.87179478 |
| 176 | Partial duplication of thumb phalanx (HP:0009944) | 1.87108589 |
| 177 | Prominent supraorbital ridges (HP:0000336) | 1.85488528 |
| 178 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.84889505 |
| 179 | Hyperkalemia (HP:0002153) | 1.84252659 |
| 180 | Supernumerary nipples (HP:0002558) | 1.84201100 |
| 181 | Abnormality of the pubic bones (HP:0003172) | 1.83471721 |
| 182 | Shawl scrotum (HP:0000049) | 1.82576938 |
| 183 | Renal dysplasia (HP:0000110) | 1.82307003 |
| 184 | Abnormality of the anterior chamber (HP:0000593) | 1.82041981 |
| 185 | Abnormal EKG (HP:0003115) | 1.81775538 |
| 186 | Vitreoretinal degeneration (HP:0000655) | 1.80773527 |
| 187 | Trigonocephaly (HP:0000243) | 1.80385797 |
| 188 | Partial duplication of the phalanx of hand (HP:0009999) | 1.79962698 |
| 189 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 1.79640371 |
| 190 | Pigmentary retinal degeneration (HP:0001146) | 1.79258934 |
| 191 | Abnormality of the nasolacrimal system (HP:0000614) | 1.77249392 |
| 192 | Renal duplication (HP:0000075) | 1.76134118 |
| 193 | Specific learning disability (HP:0001328) | 1.73143585 |
| 194 | Abnormality of chromosome segregation (HP:0002916) | 1.73115042 |
| 195 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.72990472 |
| 196 | Anophthalmia (HP:0000528) | 1.72182287 |
| 197 | Choroideremia (HP:0001139) | 1.71534265 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 4.21758646 |
| 2 | BCR | 4.02255636 |
| 3 | SMG1 | 3.89839720 |
| 4 | INSRR | 3.82992463 |
| 5 | SIK3 | 3.71176424 |
| 6 | TAF1 | 3.57555491 |
| 7 | GRK5 | 3.57144011 |
| 8 | TRIB3 | 3.51260492 |
| 9 | TESK1 | 3.42365109 |
| 10 | GRK1 | 2.81507444 |
| 11 | STK38L | 2.80293815 |
| 12 | VRK2 | 2.73603795 |
| 13 | ERBB3 | 2.62011120 |
| 14 | CDK12 | 2.57689989 |
| 15 | WNK3 | 2.54907394 |
| 16 | MYLK | 2.44460228 |
| 17 | TYRO3 | 2.39054221 |
| 18 | NTRK2 | 2.35873907 |
| 19 | PRKD3 | 2.34110700 |
| 20 | MARK1 | 2.24626458 |
| 21 | PNCK | 2.17619521 |
| 22 | DYRK2 | 2.16053807 |
| 23 | NEK9 | 2.08363970 |
| 24 | TIE1 | 2.00309279 |
| 25 | ICK | 1.95216041 |
| 26 | EEF2K | 1.91787287 |
| 27 | UHMK1 | 1.82772174 |
| 28 | TLK1 | 1.73370247 |
| 29 | SCYL2 | 1.72968573 |
| 30 | EPHB2 | 1.72902950 |
| 31 | KSR1 | 1.71621239 |
| 32 | PRKAA2 | 1.69987269 |
| 33 | KDR | 1.61471829 |
| 34 | CDC42BPA | 1.60901122 |
| 35 | CDK19 | 1.60684356 |
| 36 | PAK6 | 1.55670706 |
| 37 | MINK1 | 1.55503305 |
| 38 | GRK6 | 1.54694202 |
| 39 | ADRBK2 | 1.54655409 |
| 40 | MAPK15 | 1.50667532 |
| 41 | ERN1 | 1.50470887 |
| 42 | MAPKAPK3 | 1.49024518 |
| 43 | ARAF | 1.46917240 |
| 44 | ABL2 | 1.44159274 |
| 45 | PLK4 | 1.40737423 |
| 46 | MAPKAPK5 | 1.40628722 |
| 47 | LIMK1 | 1.39897786 |
| 48 | DYRK1B | 1.38855112 |
| 49 | STK38 | 1.38695694 |
| 50 | NTRK1 | 1.34780659 |
| 51 | MAP3K6 | 1.31062252 |
| 52 | MAP2K4 | 1.30638464 |
| 53 | MAPK4 | 1.29283216 |
| 54 | RIPK1 | 1.27230541 |
| 55 | DYRK1A | 1.26833720 |
| 56 | NEK1 | 1.26569671 |
| 57 | MAPK12 | 1.24615408 |
| 58 | MAPK11 | 1.22376013 |
| 59 | CDK18 | 1.21423928 |
| 60 | ERBB2 | 1.20016337 |
| 61 | MATK | 1.18157004 |
| 62 | KSR2 | 1.12653184 |
| 63 | ADRBK1 | 1.12289141 |
| 64 | TGFBR2 | 1.08597806 |
| 65 | CAMK1 | 1.07952380 |
| 66 | CDK14 | 1.03880308 |
| 67 | CDK15 | 1.03117608 |
| 68 | WNK1 | 1.00498925 |
| 69 | CASK | 1.00498176 |
| 70 | CDK7 | 0.97914677 |
| 71 | CDK5 | 0.95850414 |
| 72 | BRAF | 0.95455214 |
| 73 | CAMK4 | 0.95062005 |
| 74 | OXSR1 | 0.94139339 |
| 75 | CDK11A | 0.90757411 |
| 76 | AKT2 | 0.90341350 |
| 77 | PDPK1 | 0.90105492 |
| 78 | PKN1 | 0.89756414 |
| 79 | CSF1R | 0.89014720 |
| 80 | ALK | 0.85966877 |
| 81 | LATS2 | 0.85561002 |
| 82 | MARK2 | 0.85078483 |
| 83 | MAP3K4 | 0.84424710 |
| 84 | MST1R | 0.82058950 |
| 85 | FGFR2 | 0.81446937 |
| 86 | MAP3K10 | 0.81397832 |
| 87 | TBK1 | 0.80974717 |
| 88 | TTN | 0.80742763 |
| 89 | FER | 0.79962973 |
| 90 | LATS1 | 0.79345146 |
| 91 | MAPK7 | 0.79111784 |
| 92 | CAMK1G | 0.76796221 |
| 93 | MAP2K1 | 0.76766165 |
| 94 | GRK7 | 0.76741584 |
| 95 | OBSCN | 0.75947541 |
| 96 | PAK3 | 0.75013249 |
| 97 | SIK2 | 0.70124782 |
| 98 | BLK | 0.69181429 |
| 99 | WEE1 | 0.68122738 |
| 100 | TNIK | 0.67312892 |
| 101 | ILK | 0.67228444 |
| 102 | DMPK | 0.65941982 |
| 103 | IRAK2 | 0.64050338 |
| 104 | MAP2K6 | 0.62204400 |
| 105 | EPHA2 | 0.62174842 |
| 106 | NME2 | 0.62112407 |
| 107 | FGFR1 | 0.61275686 |
| 108 | IRAK3 | 0.61059728 |
| 109 | NTRK3 | 0.60640724 |
| 110 | TRPM7 | 0.60256121 |
| 111 | PDGFRA | 0.59287885 |
| 112 | PRKAA1 | 0.57902813 |
| 113 | HIPK2 | 0.57733024 |
| 114 | BCKDK | 0.56614161 |
| 115 | AURKA | 0.55035512 |
| 116 | MAP3K3 | 0.53949236 |
| 117 | DYRK3 | 0.53720446 |
| 118 | MAP3K1 | 0.53022024 |
| 119 | FGFR3 | 0.52022055 |
| 120 | BMPR1B | 0.51507787 |
| 121 | STK16 | 0.51052448 |
| 122 | DDR2 | 0.50898888 |
| 123 | SIK1 | 0.48297103 |
| 124 | PRKD1 | 0.48263662 |
| 125 | TTK | 0.48075854 |
| 126 | STK11 | 0.47401099 |
| 127 | CSNK1E | 0.46892715 |
| 128 | MAPK13 | 0.45920973 |
| 129 | PRKG2 | 0.44874299 |
| 130 | FGFR4 | 0.44728757 |
| 131 | PIK3CG | 0.43085508 |
| 132 | MAPK10 | 0.43038030 |
| 133 | MAPK9 | 0.42604538 |
| 134 | ROCK1 | 0.42233641 |
| 135 | LMTK2 | 0.42190259 |
| 136 | CDK9 | 0.41946105 |
| 137 | ERBB4 | 0.41523620 |
| 138 | MOS | 0.38396559 |
| 139 | CDK4 | 0.37975347 |
| 140 | CAMK1D | 0.37788826 |
| 141 | PRKCH | 0.37511355 |
| 142 | PHKG2 | 0.36799588 |
| 143 | PHKG1 | 0.36799588 |
| 144 | STK10 | 0.36382604 |
| 145 | DAPK3 | 0.36187792 |
| 146 | SGK223 | 0.35591391 |
| 147 | SGK494 | 0.35591391 |
| 148 | PDK1 | 0.35392417 |
| 149 | STK39 | 0.35227264 |
| 150 | RPS6KA2 | 0.34742006 |
| 151 | PRKACB | 0.34305000 |
| 152 | CHEK2 | 0.33164180 |
| 153 | PRKG1 | 0.32827634 |
| 154 | CSNK1G3 | 0.32015694 |
| 155 | GSK3A | 0.31969176 |
| 156 | PRKCG | 0.30805491 |
| 157 | MTOR | 0.30751320 |
| 158 | DAPK1 | 0.30524769 |
| 159 | TAOK1 | 0.29914953 |
| 160 | VRK1 | 0.29304379 |
| 161 | CSNK1A1L | 0.28770965 |
| 162 | CSK | 0.28531336 |
| 163 | MAP3K13 | 0.28502525 |
| 164 | CCNB1 | 0.26755887 |
| 165 | PRKACG | 0.26356707 |
| 166 | RPS6KA6 | 0.25520822 |
| 167 | TYK2 | 0.23656019 |
| 168 | MAP3K2 | 0.22817494 |
| 169 | PRKACA | 0.21472793 |
| 170 | CSNK1G2 | 0.21039628 |
| 171 | PKN2 | 0.20445382 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 4.95956504 |
| 2 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 4.32453337 |
| 3 | PPAR signaling pathway_Homo sapiens_hsa03320 | 4.20386817 |
| 4 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 3.93524647 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 3.38827804 |
| 6 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.14715985 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.11730757 |
| 8 | Tyrosine metabolism_Homo sapiens_hsa00350 | 3.03518321 |
| 9 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.00387433 |
| 10 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.70338218 |
| 11 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.57471059 |
| 12 | Axon guidance_Homo sapiens_hsa04360 | 2.47187034 |
| 13 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 2.30613968 |
| 14 | GABAergic synapse_Homo sapiens_hsa04727 | 2.29951601 |
| 15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.27745944 |
| 16 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.23199315 |
| 17 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.13687472 |
| 18 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 2.13147616 |
| 19 | Basal cell carcinoma_Homo sapiens_hsa05217 | 2.11507317 |
| 20 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.05993366 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.01482603 |
| 22 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.97919970 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.89931948 |
| 24 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.82888717 |
| 25 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.82263927 |
| 26 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.79726715 |
| 27 | Morphine addiction_Homo sapiens_hsa05032 | 1.77780172 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.77177942 |
| 29 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.76281078 |
| 30 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.74089654 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.69387879 |
| 32 | Circadian entrainment_Homo sapiens_hsa04713 | 1.64496547 |
| 33 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.60060851 |
| 34 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.59279287 |
| 35 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.56039686 |
| 36 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.53868070 |
| 37 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.39066535 |
| 38 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.37771413 |
| 39 | Endometrial cancer_Homo sapiens_hsa05213 | 1.34739145 |
| 40 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.34338323 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.32857610 |
| 42 | Olfactory transduction_Homo sapiens_hsa04740 | 1.31292047 |
| 43 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.30480344 |
| 44 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.30393957 |
| 45 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.28516934 |
| 46 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.26012408 |
| 47 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.25465813 |
| 48 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.25006677 |
| 49 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.23565949 |
| 50 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.21758963 |
| 51 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.19927686 |
| 52 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.18631272 |
| 53 | Taste transduction_Homo sapiens_hsa04742 | 1.15905797 |
| 54 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.15629322 |
| 55 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.14761522 |
| 56 | Insulin secretion_Homo sapiens_hsa04911 | 1.14735360 |
| 57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.14291846 |
| 58 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.12558306 |
| 59 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.11171435 |
| 60 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.10681718 |
| 61 | Colorectal cancer_Homo sapiens_hsa05210 | 1.09272455 |
| 62 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.07858501 |
| 63 | Gap junction_Homo sapiens_hsa04540 | 1.07632524 |
| 64 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.07327933 |
| 65 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.06647236 |
| 66 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.04529544 |
| 67 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.02913978 |
| 68 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.01586499 |
| 69 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.99571979 |
| 70 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.99032335 |
| 71 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.98893656 |
| 72 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.97998052 |
| 73 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.97324444 |
| 74 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.96634690 |
| 75 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.96360325 |
| 76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.95758458 |
| 77 | Tight junction_Homo sapiens_hsa04530 | 0.93024982 |
| 78 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.90497965 |
| 79 | Carbon metabolism_Homo sapiens_hsa01200 | 0.89662309 |
| 80 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.87867974 |
| 81 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.87182368 |
| 82 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.86071050 |
| 83 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.85764068 |
| 84 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.85093767 |
| 85 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.84573282 |
| 86 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.84066714 |
| 87 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.82061147 |
| 88 | Alzheimers disease_Homo sapiens_hsa05010 | 0.80336972 |
| 89 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.79848144 |
| 90 | Focal adhesion_Homo sapiens_hsa04510 | 0.78774208 |
| 91 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.77449321 |
| 92 | Melanogenesis_Homo sapiens_hsa04916 | 0.74850873 |
| 93 | Galactose metabolism_Homo sapiens_hsa00052 | 0.74441044 |
| 94 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.74344810 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.74323372 |
| 96 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.73497874 |
| 97 | Parkinsons disease_Homo sapiens_hsa05012 | 0.71985884 |
| 98 | Pathways in cancer_Homo sapiens_hsa05200 | 0.71682499 |
| 99 | Bladder cancer_Homo sapiens_hsa05219 | 0.70639661 |
| 100 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.70074450 |
| 101 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.69341426 |
| 102 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68966938 |
| 103 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.68653698 |
| 104 | Alcoholism_Homo sapiens_hsa05034 | 0.66605197 |
| 105 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.66239965 |
| 106 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.65115414 |
| 107 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64889992 |
| 108 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.63707326 |
| 109 | Salivary secretion_Homo sapiens_hsa04970 | 0.63205027 |
| 110 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.63184970 |
| 111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.63159987 |
| 112 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.62976693 |
| 113 | Lysine degradation_Homo sapiens_hsa00310 | 0.62913657 |
| 114 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.62127460 |
| 115 | Long-term potentiation_Homo sapiens_hsa04720 | 0.61304459 |
| 116 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.60645124 |
| 117 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.59864378 |
| 118 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.58906647 |
| 119 | Long-term depression_Homo sapiens_hsa04730 | 0.58844817 |
| 120 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56824037 |
| 121 | Retinol metabolism_Homo sapiens_hsa00830 | 0.55589296 |
| 122 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.55552346 |
| 123 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.55289788 |
| 124 | Glioma_Homo sapiens_hsa05214 | 0.54095198 |
| 125 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.51473160 |
| 126 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.49049446 |
| 127 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.47501703 |
| 128 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.46397318 |
| 129 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.45690068 |
| 130 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.45557189 |
| 131 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.44342516 |
| 132 | Sulfur relay system_Homo sapiens_hsa04122 | 0.44248669 |
| 133 | Renin secretion_Homo sapiens_hsa04924 | 0.43622793 |
| 134 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.43416869 |
| 135 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.42787298 |
| 136 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.40721108 |
| 137 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.39305674 |
| 138 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.38487888 |
| 139 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38136688 |
| 140 | Melanoma_Homo sapiens_hsa05218 | 0.36056873 |
| 141 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.34939039 |
| 142 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.34395505 |
| 143 | Endocytosis_Homo sapiens_hsa04144 | 0.34200517 |
| 144 | Adherens junction_Homo sapiens_hsa04520 | 0.34077767 |
| 145 | Peroxisome_Homo sapiens_hsa04146 | 0.33788689 |
| 146 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.33055881 |
| 147 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.32444585 |
| 148 | Huntingtons disease_Homo sapiens_hsa05016 | 0.32187496 |
| 149 | Malaria_Homo sapiens_hsa05144 | 0.31513407 |
| 150 | Thyroid cancer_Homo sapiens_hsa05216 | 0.29339473 |
| 151 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.27759064 |
| 152 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27475745 |
| 153 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.27398068 |
| 154 | ABC transporters_Homo sapiens_hsa02010 | 0.27157787 |
| 155 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.24748887 |
| 156 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.24689634 |
| 157 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.23082327 |
| 158 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.21680126 |
| 159 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.19439914 |
| 160 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.17655909 |
| 161 | Prion diseases_Homo sapiens_hsa05020 | 0.17609196 |
| 162 | Metabolic pathways_Homo sapiens_hsa01100 | 0.17489144 |
| 163 | Prostate cancer_Homo sapiens_hsa05215 | 0.16421657 |
| 164 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.16017156 |
| 165 | Viral myocarditis_Homo sapiens_hsa05416 | 0.15256297 |

